Brivanib Catalog No.:M10926-10 and TF in synovial fibroblasts

and TF in synovial fibroblasts

InChi: InChI=1S/C26H27FN2O2/c1-17-12-18(2)14-21(13-17)24-4-3-11-29(24)16-19-5-8-22(9-6-19)31-25-10-7-20(26(28)30)15-23(25)27/h5-10

Smiles: [Fe+3]

and 100 mg/kg

Smiles: CC(=O)N1[C@@H](C)C[C@@H](NC2C=CC(Cl)=CC=2)C2=CC(=CC=C12)C1C=CC(=CC=1)C(O)=O

Brivanib Catalog No.:M10926-10 and TF in synovial fibroblastsBrivanib is the hydrolyzed form of Brivanib alaninate, which is a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression. Product information CAS